Technical Analysis for SNDX - Syndax Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 14.19 | -4.51% | -0.67 |
SNDX closed down 4.51 percent on Thursday, April 22, 2021, on 1.92 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: May 5
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical SNDX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -4.51% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible NR7 | about 13 hours ago |
| Possible Inside Day | about 13 hours ago |
| Down 5% | about 17 hours ago |
| 2x Volume Pace | about 17 hours ago |
| 1.5x Volume Pace | about 17 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/05/2021
Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company's lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its Entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. The company has a collaborative research and development agreement with the National Cancer Institute; and Genentech. Syndax Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Solid Tumors Breast Cancer Treatment Of Breast Cancer Antineoplastic Drugs Cancer Cell Cancer Therapies Lung Cancer Hematological Malignancies Pyridines Late Stage Biopharmaceutical National Cancer Institute Benzamides Carbamates Histone Deacetylase Inhibitor
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Solid Tumors Breast Cancer Treatment Of Breast Cancer Antineoplastic Drugs Cancer Cell Cancer Therapies Lung Cancer Hematological Malignancies Pyridines Late Stage Biopharmaceutical National Cancer Institute Benzamides Carbamates Histone Deacetylase Inhibitor
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.85 |
| 52 Week Low | 11.27 |
| Average Volume | 953,639 |
| 200-Day Moving Average | 19.65 |
| 50-Day Moving Average | 22.30 |
| 20-Day Moving Average | 21.01 |
| 10-Day Moving Average | 18.90 |
| Average True Range | 1.86 |
| ADX | 20.94 |
| +DI | 10.40 |
| -DI | 37.34 |
| Chandelier Exit (Long, 3 ATRs ) | 20.11 |
| Chandelier Exit (Short, 3 ATRs ) | 18.59 |
| Upper Bollinger Band | 27.44 |
| Lower Bollinger Band | 14.59 |
| Percent B (%b) | -0.03 |
| BandWidth | 61.12 |
| MACD Line | -1.94 |
| MACD Signal Line | -1.00 |
| MACD Histogram | -0.9399 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.42 | ||||
| Resistance 3 (R3) | 15.48 | 15.12 | 15.22 | ||
| Resistance 2 (R2) | 15.12 | 14.81 | 15.10 | 15.15 | |
| Resistance 1 (R1) | 14.66 | 14.62 | 14.48 | 14.60 | 15.08 |
| Pivot Point | 14.30 | 14.30 | 14.22 | 14.28 | 14.30 |
| Support 1 (S1) | 13.84 | 13.99 | 13.66 | 13.78 | 13.30 |
| Support 2 (S2) | 13.48 | 13.80 | 13.46 | 13.23 | |
| Support 3 (S3) | 13.02 | 13.48 | 13.17 | ||
| Support 4 (S4) | 12.96 |
